Powered by Google-Search & Google-Books Chinese Standards Shop Database: 169759 (Oct 25, 2020)
HOME   Quotation   Tax   Examples Standard-List   Contact-Us   View-Cart
  

YY/T 1205-2013

Chinese Standard: 'YY/T 1205-2013'
Standard IDContents [version]USDSTEP2[PDF] delivered inStandard Title (Description)StatusRelated Standard
YY/T 1205-2013English150 Add to Cart 0--10 minutes. Auto immediate delivery. Total bilirubin test kit (Vanadate oxidation method) Valid YY/T 1205-2013
YY/T 1205-2013Chinese14 Add to Cart <=1-day [PDF from Chinese Authority, or Standard Committee, or Publishing House]

  In 0~10 minutes time, full copy of this English-PDF will be auto-immediately delivered to your email. See samples for translation quality.  

BASIC DATA
Standard ID YY/T 1205-2013 (YY/T1205-2013)
Description (Translated English) Total bilirubin test kit (Vanadate oxidation method)
Sector / Industry Medical Device & Pharmaceutical Industry Standard (Recommended)
Classification of Chinese Standard C44
Classification of International Standard 11.100
Word Count Estimation 8,886
Quoted Standard YY/T 0466.1
Drafting Organization Chinese Academy of Food and Drug Testing
Administrative Organization National Medical clinical testing laboratories and in vitro diagnostic systems for Standardization Technical Committee
Regulation (derived from) State Food and Drug Administration Notice No. 36 of 2013; industry standard for filing Notice 2013 No. 12 (No. 168 overall)
Proposing organization State Food and Drug Administration
Issuing agency(ies) State Food and Drug Administration
Summary This standard specifies: total bilirubin assay kit (vanadate oxidation method) requirements, test methods, marking, labeling and instructions for use, packaging, transportation and storage. This standard applies to: total bilirubin assay kit (vanadate oxi

YY/T 1205-2013
YY
ICS 11.100
C 44
PHARMACEUTICAL INDUSTRY STANDARD
OF THE PEOPLE’S REPUBLIC OF CHINA
YYY/T 1205-2013
Total bilirubin test kit (Vanadate oxidation method)
总胆红素测定试剂盒(钒酸盐氧化法)
Issued by. State Food and Drug Administration
ISSUED ON. OCTOBER 21, 2013
IMPLEMENTED ON. OCTOBER 1, 2014
Table of Contents
Foreword ... 3 
1  Scope ... 4 
2  Normative References ... 4 
3  Requirements ... 4 
4  Test Method ... 5 
5  Mark, Label and Instructions ... 7 
6  Packaging, Transport and Storage ... 8 
Foreword 
This Standard was drafted in accordance with the rules specified in GB/T 1.1-2009.
Please note that some contents in this Document may involve patents. The issuing organization of this
Document does not undertake the responsibility to identify these patents.
This Standard was proposed by State Food and Drug Administration.
This Standard shall be under the jurisdiction of the China Clinical Laboratory Testing and In vitro
Diagnostic Test System of Standardization Administration of China (SAC/TC 136).
Drafting organization of this Standard. National Institute for Food and Drug Control.
The main drafters of this Standard. Wang Yumei, Liu Yan, Wang Yumei, Gao Shangxian, and Zhang
Chuntao.
Total bilirubin test kit (Vanadate oxidation method)
1  Scope 
This standard specifies the determination principle, requirements, test method, signs, instructions,
packaging, transport and storage of total bilirubin test kit (Vanadate oxidation method).
This standard applies to the quality control of total bilirubin test kit (Vanadate oxidation method).
2  Normative References 
The following document is indispensable for the application of this document. For dated references,
only dated edition applies to this document. For undated references, the latest edition (including all
amendments) applies to this document.
YY/T 0466.1 Medical Devices. Symbols to Be Used with Medical Device Labels, Labeling and
Information to Be Supplied. Part 1. General Requirements
3  Requirements 
3.1 Appearance
It shall meet the appearance requirements specified the manufacturer.
3.2 Installed capacity
The installed capacity of liquid reagent shall not be less than the labeled amount.
3.3 Absorbance of reagent blank
The absorbance of reagent blank shall not be less than 0.050 at the wavelength of 450 nm.
3.4 Linear interval
The linear correlation coefficient (r) shall not be less than 0.9900 within the linear interval
specified by the manufacturer.
3.5 Accuracy
Use the traceable standard material to carry out the determination. The deviation between measured
value and indicated value shall be within ±10.0%.
3.6 Analysis sensitivity
The test kit shall be transported according to the requirements of the manufacturer, and shall be free
of moisture, stress, sunshine, rain, snow, acid, alkaline and damage of exterior and interior packaging
during the transport.
6.3 Storage
Test kit shall be stored under the conditions specified by the manufacturer.

YY/T 1205-2013
Total bilirubin test kit (Vanadate oxidation method)
ICS 11.100
C44
People's Republic of China pharmaceutical industry standards
Total bilirubin assay kit (vanadate oxidation method)
Issued on. 2013-10-21
2014-10-01 implementation
China Food and Drug Administration released
Foreword
This standard was drafted in accordance with GB/T 1.1-2009 given rules.
Please note that some of the content of this standard may involve patents. The standard release
Institutions do not assume the responsibility to identify these patents.
This standard was proposed by the China Food and Drug Administration.
This standard by the national medical clinical laboratory testing and in vitro diagnostic systems for Standardization Technical Committee (SAC/TC136) centralized.
This standard drafting unit. China Academy of Food and Drug test.
The main drafters of this standard. Sun Nan, Liu Yan, Wang Yumei, the first noble, Zhangchun Tao.
Total bilirubin assay kit (vanadate oxidation method)
1 Scope
This standard specifies the total bilirubin assay kit (vanadate oxidation method) requirements, test methods, marking, labeling and instructions for use, package
Loading, transport and storage.
This standard applies to the total bilirubin assay kit (vanadate oxidation method) quality control.
2 Normative references
The following documents for the application of this document is essential. For dated references, only the dated version suitable for use herein
Member. For undated references, the latest edition (including any amendments) applies to this document.
Symbols - Part 1 YY/T 0466.1 medical equipment used with medical device labels, labeling and information. General requirements
3 Requirements
3.1 Appearance
Compatible with the manufacturer's appearance requirements.
3.2 PACKING
Loading amount of the liquid reagent to be less than the labeled amount.
3.3 reagent blank absorbance
At 450nm wavelength, blank absorbance should be less than 0.050.
3.4 Linear Interval
Within the range specified by the man......
Related standard:   YY/T 1213-2019  YY/T 1196-2013
Related PDF sample:   YY/T 1213-2013  YY/T 1214-2013
   
 
Privacy   ···   Product Quality   ···   About Us   ···   Refund Policy   ···   Fair Trading   ···   Quick Response
Field Test Asia Limited | Taxed in Singapore: 201302277C | Copyright 2012-2020